News and Announcements
Introducing Shivom’s Exclusive Referral Reward Program!
- Published April 17, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom are offering an exclusive referral program to all registered members
- You can send the link to your friends and family and receive 5% bonus every time those your referred purchase OmiX tokens from their account
- This referral program is 3-tiered, which plays on network effects
If you’ve already registered to contribute to the Shivom presale, we have more exciting news to share with you!
We are offering an exclusive Shivom referral program to all of our registered members. The program can be activated by simply registering on the Tokensaledashboard – https://tokensale.shivom.io/.
How the referral program works
Following your registration/ account creation on the Shivom platform, you will receive a referral link which will be unique for every user. You can send this link to your friends and family and receive 5% bonus every time those your referred purchase OmiX tokens from their account.
The referrals program is not limited to a one-time reward. This is a 3-tier referral code that plays on network effects, which means a you will get 5% bonus for every new user and they also receive a bonus amounting to 5%, and be able to share a unique referral link with their friends, which in turn gives them 5% bonus, and gives you 4%. Subsequent sharing of the referral link again by those friends will allow you to still enjoy a 3% bonus on their purchased tokens.
Overall, for three subsequent sharings of referral links in your network will allow you to receive a bonus of 5%, 4%, and 3% from your connections.
We are extremely happy that you have made the choice to join Shivom and are thrilled to be able to reward our supporters! .
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
Relying solely on broad macroeconomic trends is the single biggest mistake property investors make today. Centuria Capital CIO Andrew Essey explains why asset-level “lettability” always trumps the overarching sector thematic, and reveals where global institutional capital is quietly pivoting to capture high-octane returns.
Backed By Leading Investment Groups and Family Offices
